Neogenomics (NEO) Leases (2016 - 2025)
Historic Leases for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $80.1 million.
- Neogenomics' Leases fell 158.64% to $80.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.1 million, marking a year-over-year decrease of 158.64%. This contributed to the annual value of $79.6 million for FY2024, which is 1327.9% down from last year.
- Neogenomics' Leases amounted to $80.1 million in Q3 2025, which was down 158.64% from $82.9 million recorded in Q2 2025.
- Over the past 5 years, Neogenomics' Leases peaked at $102.3 million during Q3 2021, and registered a low of $50.9 million during Q1 2021.
- Over the past 5 years, Neogenomics' median Leases value was $87.1 million (recorded in 2023), while the average stood at $86.5 million.
- Per our database at Business Quant, Neogenomics' Leases skyrocketed by 12320.58% in 2021 and then plummeted by 1327.9% in 2024.
- Neogenomics' Leases (Quarter) stood at $102.2 million in 2021, then fell by 5.96% to $96.1 million in 2022, then decreased by 4.52% to $91.8 million in 2023, then decreased by 13.28% to $79.6 million in 2024, then grew by 0.71% to $80.1 million in 2025.
- Its Leases stands at $80.1 million for Q3 2025, versus $82.9 million for Q2 2025 and $77.8 million for Q1 2025.